136 related articles for article (PubMed ID: 16778151)
1. Identification of a 4-mer peptide inhibitor that effectively blocks the polymerization of pathogenic Z alpha1-antitrypsin.
Chang YP; Mahadeva R; Chang WS; Shukla A; Dafforn TR; Chu YH
Am J Respir Cell Mol Biol; 2006 Nov; 35(5):540-8. PubMed ID: 16778151
[TBL] [Abstract][Full Text] [Related]
2. Preventing and reversing the cellular consequences of Z alpha-1 antitrypsin accumulation by targeting s4A.
Alam S; Wang J; Janciauskiene S; Mahadeva R
J Hepatol; 2012 Jul; 57(1):116-24. PubMed ID: 22425623
[TBL] [Abstract][Full Text] [Related]
3. 6-mer peptide selectively anneals to a pathogenic serpin conformation and blocks polymerization. Implications for the prevention of Z alpha(1)-antitrypsin-related cirrhosis.
Mahadeva R; Dafforn TR; Carrell RW; Lomas DA
J Biol Chem; 2002 Mar; 277(9):6771-4. PubMed ID: 11773044
[TBL] [Abstract][Full Text] [Related]
4. Small-molecule peptides inhibit Z alpha1-antitrypsin polymerization.
Chang YP; Mahadeva R; Chang WW; Lin SC; Chu YH
J Cell Mol Med; 2009 Aug; 13(8B):2304-2316. PubMed ID: 19120695
[TBL] [Abstract][Full Text] [Related]
5. Molecular Mechanism of Z α1-Antitrypsin Deficiency.
Huang X; Zheng Y; Zhang F; Wei Z; Wang Y; Carrell RW; Read RJ; Chen GQ; Zhou A
J Biol Chem; 2016 Jul; 291(30):15674-86. PubMed ID: 27246852
[TBL] [Abstract][Full Text] [Related]
6. Inhibiting polymerization: new therapeutic strategies for Z alpha1-antitrypsin-related emphysema.
Parfrey H; Dafforn TR; Belorgey D; Lomas DA; Mahadeva R
Am J Respir Cell Mol Biol; 2004 Aug; 31(2):133-9. PubMed ID: 15016619
[TBL] [Abstract][Full Text] [Related]
7. Expression, purification and characterization of recombinant Z alpha(1)-antitrypsin--the most common cause of alpha(1)-antitrypsin deficiency.
Levina V; Dai W; Knaupp AS; Kaiserman D; Pearce MC; Cabrita LD; Bird PI; Bottomley SP
Protein Expr Purif; 2009 Dec; 68(2):226-32. PubMed ID: 19555763
[TBL] [Abstract][Full Text] [Related]
8. Kinetic instability of the serpin Z alpha1-antitrypsin promotes aggregation.
Knaupp AS; Levina V; Robertson AL; Pearce MC; Bottomley SP
J Mol Biol; 2010 Feb; 396(2):375-83. PubMed ID: 19944704
[TBL] [Abstract][Full Text] [Related]
9. The shapes of Z-α1-antitrypsin polymers in solution support the C-terminal domain-swap mechanism of polymerization.
Behrens MA; Sendall TJ; Pedersen JS; Kjeldgaard M; Huntington JA; Jensen JK
Biophys J; 2014 Oct; 107(8):1905-1912. PubMed ID: 25418171
[TBL] [Abstract][Full Text] [Related]
10. A Novel Small Molecule Inhibits Intrahepatocellular Accumulation of Z-Variant Alpha 1-Antitrypsin In Vitro and In Vivo.
Zhang X; Pham K; Li D; Schutte RJ; Gonzalo DH; Zhang P; Oshins R; Tan W; Brantly M; Liu C; Ostrov DA
Cells; 2019 Dec; 8(12):. PubMed ID: 31817705
[TBL] [Abstract][Full Text] [Related]
11. Defining the mechanism of polymerization in the serpinopathies.
Ekeowa UI; Freeke J; Miranda E; Gooptu B; Bush MF; Pérez J; Teckman J; Robinson CV; Lomas DA
Proc Natl Acad Sci U S A; 2010 Oct; 107(40):17146-51. PubMed ID: 20855577
[TBL] [Abstract][Full Text] [Related]
12. Discovery of an inhibitor of Z-alpha1 antitrypsin polymerization.
Berthelier V; Harris JB; Estenson KN; Baudry J
PLoS One; 2015; 10(5):e0126256. PubMed ID: 25961288
[TBL] [Abstract][Full Text] [Related]
13. Loop-sheet polymerization: the structural basis of Z alpha 1-antitrypsin accumulation in the liver.
Lomas DA
Clin Sci (Lond); 1994 May; 86(5):489-95. PubMed ID: 8033502
[TBL] [Abstract][Full Text] [Related]
14. High-resolution ex vivo NMR spectroscopy of human Z α
Jagger AM; Waudby CA; Irving JA; Christodoulou J; Lomas DA
Nat Commun; 2020 Dec; 11(1):6371. PubMed ID: 33311470
[TBL] [Abstract][Full Text] [Related]
15. A single-chain variable fragment intrabody prevents intracellular polymerization of Z α1-antitrypsin while allowing its antiproteinase activity.
Ordóñez A; Pérez J; Tan L; Dickens JA; Motamedi-Shad N; Irving JA; Haq I; Ekeowa U; Marciniak SJ; Miranda E; Lomas DA
FASEB J; 2015 Jun; 29(6):2667-78. PubMed ID: 25757566
[TBL] [Abstract][Full Text] [Related]
16. Alpha1-antitrypsin polymerization and the serpinopathies: pathobiology and prospects for therapy.
Lomas DA; Mahadeva R
J Clin Invest; 2002 Dec; 110(11):1585-90. PubMed ID: 12464660
[No Abstract] [Full Text] [Related]
17. Small molecules block the polymerization of Z alpha1-antitrypsin and increase the clearance of intracellular aggregates.
Mallya M; Phillips RL; Saldanha SA; Gooptu B; Brown SC; Termine DJ; Shirvani AM; Wu Y; Sifers RN; Abagyan R; Lomas DA
J Med Chem; 2007 Nov; 50(22):5357-63. PubMed ID: 17918823
[TBL] [Abstract][Full Text] [Related]
18. Practical genetics: alpha-1-antitrypsin deficiency and the serpinopathies.
Crowther DC; Belorgey D; Miranda E; Kinghorn KJ; Sharp LK; Lomas DA
Eur J Hum Genet; 2004 Mar; 12(3):167-72. PubMed ID: 14694355
[TBL] [Abstract][Full Text] [Related]
19. The pathological Trento variant of alpha-1-antitrypsin (E75V) shows nonclassical behaviour during polymerization.
Miranda E; Ferrarotti I; Berardelli R; Laffranchi M; Cerea M; Gangemi F; Haq I; Ottaviani S; Lomas DA; Irving JA; Fra A
FEBS J; 2017 Jul; 284(13):2110-2126. PubMed ID: 28504839
[TBL] [Abstract][Full Text] [Related]
20. Genetic variants of alpha1-antitrypsin.
Salahuddin P
Curr Protein Pept Sci; 2010 Mar; 11(2):101-17. PubMed ID: 19751191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
